Martin Flore-Anne, Peycelon Matthieu, Vinit Nicolas, Planchamp Thibault, Abbo Olivier, Le Lous Maela, Le Bouar Gwenaelle, Ville Yves, Paye-Jaouen Annabelle, Blanc Thomas, Arnaud Alexis P
Department of Gynecology, Obstetrics and Reproductive Medicine, CHU Rennes, Université de Rennes, Rennes, France.
Department of Pediatric Urology, National Reference Center for Rare Urinary Tract Malformations (MARVU), University Hospital Robert-Debre, APHP, Université Paris Cité, Paris, France.
Prenat Diagn. 2025 Jul;45(8):1013-1026. doi: 10.1002/pd.6773. Epub 2025 Mar 13.
The role of prenatal urinoma in lower urinary tract obstruction (LUTO) such as posterior urethral valves (PUV) is debated. We aimed to describe the risk factors associated with fetal urinoma and the association between fetal urinoma and postnatal renal function before 2 years of age.
This retrospective multicenter case-control study from 2000 to 2018 included pregnant patients with suspected LUTO in their male fetus on prenatal ultrasound and postnatal confirmation of PUV. The exposure criterion was prenatal urinoma. The main composit outcome (MCO) was chronic kidney disease stage 3 or higher (CKD3+) before 2 years or death. Descriptive analyses of patient data and crude and multivariate logistic regression analyses were performed in an intent-to-treat fashion, thus including lost-to-follow-up patients. Ethical approval # 20.144.
We included 299 patients, of whom 39 (13%) had prenatal urinoma. Thirty-eight patients had a termination of pregnancy (12.7%). Sixty-four (24.5%) patients'children were MCO positive. Twenty-one children were lost-to-follow-up, including one prenatal urinoma. Thirty-nine (60.9%) of the remaining children had CKD3+ before the age of two, of whom 6 had a prenatal urinoma (9.4%). Among the 197 children negative to the MCO, 24 had a prenatal urinoma (12.2%, p = 0.42). Four died neonatally. In livebirth patients, prenatal urinoma was associated with obstetrical complications (p = 0.02), prenatal bloodcord sample for fetal beta2-microglobulin (p = 0.01) and uro-amniotic shunt (p = 0.01). Patients with prenatal urinoma more often presented with oligohydramnios (p = 0.01) and dilated posterior urethra (p = 0.01) and were less likely to have urinary tract infections (p = 0.02), although their DMSA scan was more often altered (p = 0.001). Prenatal urinoma was not significantly associated with CKD3+ before 2 years (OR = 0.56, CI98% = 0.20-1.39, p = 0.23).
Renal function in infants with PUV was not worsened by the presence of a prenatal urinoma. Thus, there should not be any more pejorative message conveyed to concerned couples apart from other already known prenatal poor prognosis risk factors.
产前肾积水在诸如后尿道瓣膜(PUV)等下尿路梗阻(LUTO)中的作用存在争议。我们旨在描述与胎儿肾积水相关的危险因素以及胎儿肾积水与2岁前的产后肾功能之间的关联。
这项2000年至2018年的回顾性多中心病例对照研究纳入了产前超声怀疑男性胎儿存在LUTO且产后确诊为PUV的孕妇。暴露标准为产前肾积水。主要综合结局(MCO)为2岁前慢性肾脏病3期或更高分期(CKD3+)或死亡。以意向性分析的方式对患者数据进行描述性分析以及粗逻辑回归和多变量逻辑回归分析,因此包括失访患者。伦理批准号#20.144。
我们纳入了299例患者,其中39例(13%)有产前肾积水。38例患者终止妊娠(12.7%)。64例(24.5%)患者的孩子MCO呈阳性。21例儿童失访,其中1例有产前肾积水。其余儿童中有39例(60.9%)在2岁前出现CKD3+,其中6例有产前肾积水(9.4%)。在197例MCO为阴性的儿童中,24例有产前肾积水(12.2%,p = 0.42)。4例新生儿死亡。在活产患者中,产前肾积水与产科并发症(p = 0.02)、用于检测胎儿β2-微球蛋白的产前脐血样本(p = 0.01)和尿路羊膜分流术(p = 0.01)相关。有产前肾积水的患者更常出现羊水过少(p = 0.01)和后尿道扩张(p = 0.01),且尿路感染的可能性较小(p = 0.02),尽管他们的二巯基丁二酸(DMSA)扫描更常出现异常(p = 0.001)。产前肾积水与2岁前的CKD3+无显著关联(OR = 0.56,98%CI = 0.20 - 1.39,p = 0.23)。
产前肾积水的存在并未使患有PUV的婴儿的肾功能恶化。因此,除了其他已知的产前预后不良风险因素外,不应再向相关夫妇传达任何负面信息。